PTCE domain - 23.75% of the exam

Patient Safety and Quality Assurance

Patient Safety and Quality Assurance is 23.75% of the PTCE exam. These are the objectives it covers, each with practice questions, with every answer explained.

The domain in numbers

74
Practice questions
6
Objectives
12
Easy
48
Medium
14
Hard

Where people go wrong

  • Misplacing the zero in a decimal dose

    The wrong answers keep a bare decimal, add a trailing zero, or do both. A naked ".5" read without its decimal point becomes 5, a tenfold overdose, and "0.50" becomes 50 mg if the point is missed. The convention has two halves: a leading zero before a decimal below one, so 0.5 mg, and no trailing zero after it, so 25 mcg and not 25.0 mcg. When a handwritten order carries a trailing zero, the safe step is to clarify with the prescriber, not to guess.

    See it in a sample question
  • Mistaking Tall Man lettering for another safeguard

    The wrong answers either misread mixed-case lettering as a high-alert flag or a controlled-substance marker, or swap in a measure that does not separate two similar names: uniform capitals, a larger font, a high-alert sticker or a leading zero. Tall Man lettering capitalises only the letters where look-alike names differ, as in hydrALAZINE and hydrOXYzine, so the eye lands on the difference at the point of selection. Neither drug in that pair is controlled.

    See it in a sample question
  • Sending an adverse event to the wrong channel

    The wrong answers pick a reporting body that handles something else. VAERS takes adverse events after vaccination only, so a serious reaction to a tablet or to lamotrigine does not belong there. MedWatch is the FDA programme for serious adverse events and product problems with marketed drugs, but a fever after an influenza vaccination still goes to VAERS, the dedicated vaccine system. A DEA report covers theft or diversion, a state board handles professional conduct, and an internal log is not an external report when harm occurred.

    See it in a sample question
  • Calling an intercepted error an adverse reaction or sentinel event

    The wrong answers classify an error caught at verification by the harm it might have caused. An adverse drug reaction needs a real clinical response to a medicine the patient received, and a sentinel event needs actual death or serious injury. When the wrong salt form or a higher tablet strength is corrected before the patient takes any dose, it is a near miss, logged so the pharmacy can analyse it. An adverse drug event is different: harm from the use of a medicine, whether or not the dose was correct.

    See it in a sample question

Objectives in this domain

What to study

The official documents this domain's practice questions cite most.

Sample questions from this domain

Free samplePatient Safety and Quality Assurancemedium

A prescriber's handwritten order for a paediatric patient, Tobias Renwick, reads "levothyroxine 25.0 mcg daily". The technician notices the trailing zero after the decimal point. What is the technician's BEST action to prevent a dosing error before processing the order?

  • AClarify with the prescriber and ensure the dose is recorded as 25 mcg without the trailing zero Correct
  • BProcess the order as 250 mcg because the decimal point in a handwritten order is usually a stray mark
  • CAdd a leading zero so the strength is documented as 025.0 mcg for clarity
  • DKeep the trailing zero because writing 25.0 mcg shows the dose was deliberately checked to the tenth
Trailing zeros after a decimal point must be removed because a missed decimal can cause a tenfold overdose. A dose written as 25.0 mcg becomes 250 mcg if the decimal point is overlooked or smudged, a tenfold error. Removing the trailing zero so the value reads 25 mcg eliminates that misread, which is why the convention forbids trailing zeros entirely.

Why A is correct: A trailing zero after a decimal point can be misread as a tenfold higher dose if the decimal is missed, so the safe practice is to confirm intent and document the strength as 25 mcg with no trailing zero.

Why B is wrong: Assuming the decimal is a stray mark invents a tenfold overdose; the safe response to ambiguity is verification, not guessing a higher dose.

Why C is wrong: Leading zeros belong only before a decimal point for values under one; 025.0 mcg is a malformed entry that adds an unnecessary digit and keeps the dangerous trailing zero.

Why D is wrong: Retaining 25.0 mcg preserves exactly the trailing-zero hazard the rule exists to remove; documenting precision to a tenth offers no benefit and increases tenfold-overdose risk.

Free samplePatient Safety and Quality Assurancemedium

A technician at Lindfield Community Pharmacy is restocking the shelf and finds that hydrALAZINE 25 mg tablets and hydrOXYzine 25 mg tablets are stored next to each other, and both are written on the day's order as plain lowercase 'hydralazine' and 'hydroxyzine'. The pharmacist asks the technician to apply the ISMP-recommended safeguard that visually distinguishes these two products at the point of selection. Which action best meets that recommendation?

  • AMove both products to a single combined bin so the technician checks the strength before selecting either drug
  • BAdd a coloured auxiliary sticker reading 'high-alert' to each stock bottle of both medicines
  • CPrint both names entirely in capital letters on the shelf labels to make them stand out
  • DRelabel the shelf positions using Tall Man lettering so the bins read hydrALAZINE and hydrOXYzine Correct
Tall Man lettering visually emphasises the differing letters of LASA drug names to reduce wrong-drug selection at storage and entry. LASA errors arise when similar names blur together during selection; Tall Man lettering forces the eye to the segments that differ, which is why ISMP promotes it for confusable pairs rather than uppercasing or co-locating products.

Why A is wrong: Co-locating two confusable products in one bin increases the chance of grabbing the wrong drug; physical separation, not consolidation, is the recognised safeguard, so this worsens the hazard.

Why B is wrong: A generic high-alert sticker may seem protective, but neither agent is on the ISMP high-alert list and the label does not address the name-confusion problem that Tall Man lettering targets.

Why C is wrong: Full capitalisation makes a name conspicuous but does not highlight the differing letters; ISMP specifically recommends selective mixed-case emphasis rather than uniform uppercase.

Why D is correct: Tall Man lettering uses mixed-case emphasis on the differing letters, which is the ISMP-endorsed method for reducing selection errors between look-alike/sound-alike names at the storage point.

Free samplePatient Safety and Quality Assurancemedium

A patient, Tobias Renfrew, develops a severe blistering skin reaction after starting lamotrigine dispensed by the pharmacy, and is hospitalised. The pharmacist wants to report this serious adverse event to the appropriate federal surveillance programme. To which programme should the technician help direct this report?

  • AThe VAERS programme, which collects reports of adverse events that follow the administration of vaccines
  • BThe DEA diversion reporting system used for losses and thefts of controlled substances
  • CThe state board of pharmacy complaint line for unprofessional dispensing conduct
  • DThe FDA MedWatch programme, which collects reports of serious adverse events for drugs and other medical products Correct
Serious adverse events involving drugs and medical products are reported to the FDA through the MedWatch programme. MedWatch is the FDA's safety information and adverse event reporting system for human medical products such as drugs, biologics, and devices, capturing serious reactions, product quality problems, and therapeutic failures so the FDA can detect emerging safety signals.

Why A is wrong: VAERS is the correct destination for vaccine-related adverse events, which makes it tempting, but lamotrigine is a drug rather than a vaccine, so this report does not belong in VAERS.

Why B is wrong: DEA reporting addresses diversion, loss, and theft of controlled substances, which sounds official, but it has no role in capturing clinical adverse drug reactions such as a skin reaction.

Why C is wrong: A board complaint line handles professional conduct issues, which a worried candidate may reach for, but an unexpected serious drug reaction is a surveillance matter for the FDA rather than a conduct complaint.

Why D is correct: MedWatch is the FDA system for voluntary reporting of serious adverse events, product quality problems, and therapeutic failures involving drugs, biologics, and devices, so a serious lamotrigine skin reaction belongs here.

Free samplePatient Safety and Quality Assurancemedium

During final verification, a pharmacist catches that a prescription for metoprolol succinate 50 mg had been filled with metoprolol tartrate 50 mg, and corrects it before the patient, Hollis Bramwell, leaves the counter. The technician is logging the occurrence. How is this event best classified for the pharmacy's quality programme?

  • AA near miss, because the error was detected and corrected before it reached the patient Correct
  • BAn adverse drug reaction, because the patient could have been harmed by the wrong salt form
  • CA sentinel event, because it involved a high-alert cardiac medicine
  • DA reportable medication error, because the wrong product was supplied to the patient
An error intercepted before it reaches the patient is a near miss and should be logged to improve the system. A near miss is an error or unsafe condition that is caught and corrected before it reaches the patient; logging near misses lets a pharmacy study weak points in its workflow without any patient having been harmed.

Why A is correct: A near miss is an error that is intercepted before reaching the patient, so catching the wrong salt form at verification before dispensing is precisely a near miss worth logging for analysis.

Why B is wrong: An adverse drug reaction requires an actual unwanted clinical response to a medicine the patient received, which is tempting given the harm potential, but no drug reached the patient here.

Why C is wrong: Sentinel events are unexpected occurrences causing death or serious physical or psychological injury, which the cardiac context makes tempting, but no harm occurred and the error was caught.

Why D is wrong: This would apply if the wrong product had actually reached the patient, which a candidate may assume, but the pharmacist corrected it at the counter so nothing was supplied in error.

Other domains in this exam

See also the PTCE cert hub, the study guide, and the cheat sheet.

Examworthy is not affiliated with or endorsed by PTCB. Original, blueprint-aligned practice material only.